Roberto A. Rabinovich
- Validity of physical activity monitors during daily life in patients with COPDBy Roberto A. Rabinovich, Zafeiris Louvaris, Yogini Raste, Daniel Langer, Hans Van Remoortel, Santiago Giavedoni, Chris Burtin, Eloisa M.G. Regueiro, Ioannis Vogiatzis, Nicholas S. Hopkinson, Michael I. Polkey, Frederick J. Wilson, William MacNee, Klaas R. Westerterp and Thierry TroostersRoberto A. Rabinovich1ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh8Both authors contributed equallyZafeiris Louvaris2Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, Greece8Both authors contributed equallyYogini Raste3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College London, LondonDaniel Langer4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumHans Van Remoortel4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumSantiago Giavedoni1ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, EdinburghChris Burtin4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, BelgiumEloisa M.G. Regueiro5Laboratory of Respiratory Physiotherapy, Universidade Federal de São Carlos (UFSCar), São Carlos, BrazilIoannis Vogiatzis2Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, GreeceNicholas S. Hopkinson3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College London, LondonMichael I. Polkey3NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College London, LondonFrederick J. Wilson6Precision Medicine, Pfizer Worldwide Research and Development, Sandwich, UKWilliam MacNee1ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen’s Medical Research Institute, University of Edinburgh, EdinburghKlaas R. Westerterp7Dept of Human Biology, Maastricht University, Maastricht, The NetherlandsThierry Troosters4Dept of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences, Katholieke Universiteit Leuven, Leuven, Belgium
- Determinants and outcomes of physical activity in patients with COPDBy Elena Gimeno-Santos, Anja Frei, Jordi de Batlle, Claudia Steurer-Stey, Milo A. Puhan, Hans Van Remoortel, Thierry Troosters, Yogini Raste, Nicholas S. Hopkinson, Michael I. Polkey, Roberto A. Rabinovich, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainAnja Frei2Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandJordi de Batlle1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, SpainClaudia Steurer-Stey3Institute of General Practice and Health Services Research, University Hospital of Zurich, Zurich, SwitzerlandMilo A. Puhan2Horten Centre for Patient-Oriented Research, University Hospital of Zurich, Zurich, SwitzerlandHans Van Remoortel4Department of Rehabilitation Sciences, Katholieke University of Leuven, Leuven, BelgiumThierry Troosters4Department of Rehabilitation Sciences, Katholieke University of Leuven, Leuven, BelgiumYogini Raste5NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United KingdomNicholas S. Hopkinson5NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United KingdomMichael I. Polkey5NIHR Respiratory Biomedical Research Unit, Royal Brompton Hospital, London, United KingdomRoberto A. Rabinovich6ELEGI/Colt Laboratory UoE/MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United KingdomNiklas Karlsson7R&D, Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology, (CREAL), Barcelona, Spain
- Ageing and the border between health and diseaseBy William MacNee, Roberto A. Rabinovich and Gourab ChoudhuryArticle | Published in 2014 in European Respiratory JournalWilliam MacNeeELEGI Colt Research Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UKRoberto A. RabinovichELEGI Colt Research Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UKGourab ChoudhuryELEGI Colt Research Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
- Ageing and the border between health and diseaseBy William MacNee, Roberto A. Rabinovich and Gourab ChoudhuryWilliam MacNeeELEGI Colt Research Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UKRoberto A. RabinovichELEGI Colt Research Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UKGourab ChoudhuryELEGI Colt Research Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichArticle | Published in 2015 in European Respiratory JournalElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichArticle | Published in 2015 in European Respiratory JournalElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary diseaseBy Elena Gimeno-Santos, Yogini Raste, Heleen Demeyer, Zafeiris Louvaris, Corina de Jong, Roberto A. Rabinovich, Nicholas S. Hopkinson, Michael I. Polkey, Ioannis Vogiatzis, Maggie Tabberer, Fabienne Dobbels, Nathalie Ivanoff, Willem I. de Boer, Thys van der Molen, Karoly Kulich, Ignasi Serra, Xavier Basagaña, Thierry Troosters, Milo A. Puhan, Niklas Karlsson and Judith Garcia-AymerichElena Gimeno-Santos1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain4FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, SpainYogini Raste5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKHeleen Demeyer6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumZafeiris Louvaris7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceCorina de Jong8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsRoberto A. Rabinovich9ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UKNicholas S. Hopkinson5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKMichael I. Polkey5National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College, London, UKIoannis Vogiatzis7Department of Critical Care Medicine and Pulmonary Services, Thorax Foundation, Athens, GreeceMaggie Tabberer10Value Evidence and Outcomes, GlaxoSmithKline R&D, Uxbridge, UKFabienne Dobbels11Health Services and Nursing Research, Department of Public Health and Primary Care, University of Leuven, Leuven, BelgiumNathalie Ivanoff12Almirall S.A., Barcelona, SpainWillem I. de Boer13Lung Foundation Netherlands, Amersfoort, The NetherlandsThys van der Molen8Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsKaroly Kulich14PRO Expert, Novartis Pharma, Basel, SwitzerlandIgnasi Serra1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainXavier Basagaña1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, SpainThierry Troosters6Department of Rehabilitation Sciences, Faculty of Kinesiology and Rehabilitation Sciences and Respiratory Division, University Hospital Leuven, Leuven, BelgiumMilo A. Puhan15Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, SwitzerlandNiklas Karlsson16Health Economics and Outcomes Research, AstraZeneca R&D, Mölndal, SwedenJudith Garcia-Aymerich1Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain2Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain3Universitat Pompeu Fabra (UPF), Barcelona, Spain
- Can health status questionnaires be used as a measure of physical activity in COPD patients?By Heleen Demeyer, Ivan Dueñas-Espín, Corina De Jongh, Zafeiris Louvaris, Miek Hornikx, Elena Gimeno-Santos, Matthias Loeckx, Ioannis Vogiatzis, Wim Janssens, Nicholas S. Hopkinson, Roberto A. Rabinovich, Niklas Karlsson, Judith Garcia-Aymerich and Thierry TroostersArticle | Published in 2016 in European Respiratory JournalHeleen Demeyer1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumIvan Dueñas-Espín3Centre for Research in Environmental Epidemiology, Barcelona, Spain4CIBER Epidemiología y Salud Pública, Barcelona, Spain5Universitat Pompeu Fabra, Barcelona, SpainCorina De Jongh6Dept of General Practice, University Medical Center Groningen, Groningen, NetherlandsZafeiris Louvaris7Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, GreeceMiek Hornikx1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumElena Gimeno-Santos3Centre for Research in Environmental Epidemiology, Barcelona, Spain4CIBER Epidemiología y Salud Pública, Barcelona, Spain5Universitat Pompeu Fabra, Barcelona, SpainMatthias Loeckx1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumIoannis Vogiatzis7Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, GreeceWim Janssens2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumNicholas S. Hopkinson8NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS foundation Trust and Imperial College London, London, UKRoberto A. Rabinovich9ELEGI/Colt laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UKNiklas Karlsson10Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich3Centre for Research in Environmental Epidemiology, Barcelona, Spain4CIBER Epidemiología y Salud Pública, Barcelona, Spain5Universitat Pompeu Fabra, Barcelona, SpainThierry Troosters1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, Belgium
- Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDBy Roberto A. Rabinovich, Bruce E. Miller, Karolina Wrobel, Kareshma Ranjit, Michelle C. Williams, Ellen Drost, Lisa D. Edwards, David A. Lomas, Stephen I. Rennard, Alvar Agustí, Ruth Tal-Singer, Jørgen Vestbo, Emiel F.M. Wouters, Michelle John, Edwin J.R. van Beek, John T Murchison, Charlotte E Bolton, William MacNee and Jeffrey T.J. HuangArticle | Published in 2016 in European Respiratory JournalRoberto A. Rabinovich1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKBruce E. Miller2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAKarolina Wrobel3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UKKareshma Ranjit1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKMichelle C. Williams4University/BHF Centre for Cardiovascular Science, Edinburgh, UKEllen Drost1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKLisa D. Edwards5PAREXEL International, Durham, NC, USADavid A. Lomas6Faculty of Medical Sciences, University College London, London, UKStephen I. Rennard7Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA8Clinical Discovery Unit, AstraZeneca, Cambridge, UKAlvar Agustí9Servei de Pneumologia, Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, SpainRuth Tal-Singer2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAJørgen Vestbo10Centre for Respiratory Medicine and Allergy, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UKEmiel F.M. Wouters11Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The NetherlandsMichelle John12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKEdwin J.R. van Beek13Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, UKJohn T Murchison14Dept of Radiology, Royal Infirmary of Edinburgh, UKCharlotte E Bolton12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKWilliam MacNee1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKJeffrey T.J. Huang3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UK
- Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPDBy Roberto A. Rabinovich, Bruce E. Miller, Karolina Wrobel, Kareshma Ranjit, Michelle C. Williams, Ellen Drost, Lisa D. Edwards, David A. Lomas, Stephen I. Rennard, Alvar Agustí, Ruth Tal-Singer, Jørgen Vestbo, Emiel F.M. Wouters, Michelle John, Edwin J.R. van Beek, John T Murchison, Charlotte E Bolton, William MacNee and Jeffrey T.J. HuangRoberto A. Rabinovich1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKBruce E. Miller2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAKarolina Wrobel3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UKKareshma Ranjit1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKMichelle C. Williams4University/BHF Centre for Cardiovascular Science, Edinburgh, UKEllen Drost1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKLisa D. Edwards5PAREXEL International, Durham, NC, USADavid A. Lomas6Faculty of Medical Sciences, University College London, London, UKStephen I. Rennard7Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska, Omaha, NE, USA8Clinical Discovery Unit, AstraZeneca, Cambridge, UKAlvar Agustí9Servei de Pneumologia, Thorax Institute, Hospital Clinic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias (CIBERES), Barcelona, SpainRuth Tal-Singer2Respiratory Therapy Area Unit, GSK, King of Prussia, PA, USAJørgen Vestbo10Centre for Respiratory Medicine and Allergy, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UKEmiel F.M. Wouters11Dept of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The NetherlandsMichelle John12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKEdwin J.R. van Beek13Clinical Research Imaging Centre, Queens Medical Research Institute, Edinburgh, UKJohn T Murchison14Dept of Radiology, Royal Infirmary of Edinburgh, UKCharlotte E Bolton12Nottingham Respiratory Research Unit, School of Medicine, University of Nottingham, Nottingham, UKWilliam MacNee1Edinburgh Lung and the Environment Group Initiative (ELEGI), Centre for Inflammation and Research, Queens' Medical Research Institute, Edinburgh, UKJeffrey T.J. Huang3Medical Research Institute, School of Medicine, University of Dundee, Dundee, UK
- Can health status questionnaires be used as a measure of physical activity in COPD patients?By Heleen Demeyer, Ivan Dueñas-Espín, Corina De Jongh, Zafeiris Louvaris, Miek Hornikx, Elena Gimeno-Santos, Matthias Loeckx, Ioannis Vogiatzis, Wim Janssens, Nicholas S. Hopkinson, Roberto A. Rabinovich, Niklas Karlsson, Judith Garcia-Aymerich and Thierry TroostersHeleen Demeyer1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumIvan Dueñas-Espín3Centre for Research in Environmental Epidemiology, Barcelona, Spain4CIBER Epidemiología y Salud Pública, Barcelona, Spain5Universitat Pompeu Fabra, Barcelona, SpainCorina De Jongh6Dept of General Practice, University Medical Center Groningen, Groningen, NetherlandsZafeiris Louvaris7Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, GreeceMiek Hornikx1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumElena Gimeno-Santos3Centre for Research in Environmental Epidemiology, Barcelona, Spain4CIBER Epidemiología y Salud Pública, Barcelona, Spain5Universitat Pompeu Fabra, Barcelona, SpainMatthias Loeckx1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumIoannis Vogiatzis7Dept of Critical Care Medicine, Pulmonary Rehabilitation Centre, Evangelismos Hospital, M. Simou and G.P. Livanos Laboratories, National and Kapodistrian University of Athens, Thorax Foundation, Athens, GreeceWim Janssens2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, BelgiumNicholas S. Hopkinson8NIHR Respiratory Biomedical Research Unit of the Royal Brompton and Harefield NHS foundation Trust and Imperial College London, London, UKRoberto A. Rabinovich9ELEGI/Colt laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UKNiklas Karlsson10Astra Zeneca, Mölndal, SwedenJudith Garcia-Aymerich3Centre for Research in Environmental Epidemiology, Barcelona, Spain4CIBER Epidemiología y Salud Pública, Barcelona, Spain5Universitat Pompeu Fabra, Barcelona, SpainThierry Troosters1KU Leuven–University of Leuven, Department of Rehabilitation Sciences, Leuven, Belgium2University Hospitals Leuven, Department of Respiratory Diseases, Leuven, Belgium
- Interventions to modify physical activity in patients with COPD: a systematic reviewBy Leandro Cruz Mantoani, Noah Rubio, Brian McKinstry, William MacNee and Roberto A. RabinovichArticle | Published in 2016 in European Respiratory JournalLeandro Cruz Mantoani1ELEGI and COLT Laboratories, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UKNoah Rubio1ELEGI and COLT Laboratories, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UKBrian McKinstry2Edinburgh Health Services Research Unit/Edinburgh Clinical Trials Unit, Western General Hospital, Edinburgh, UK3Telescot Research Programme, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UKWilliam MacNee1ELEGI and COLT Laboratories, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UKRoberto A. Rabinovich1ELEGI and COLT Laboratories, The Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
